CSIMarket
 


Liquidia Corporation  (LQDA)
Other Ticker:  
 


Liquidia's Gross Profit Margin by quarter

Trends, Rankings, Statistics



LQDA Gross Profit Margin (Dec 31 2023)
IV. Quarter
(Sep 30 2023)
III. Quarter
(Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
Y / Y Revenue Change -15.47 % 16.21 % 22.15 % 28.67 % 66.72 %
Seq. Revenue Change 23.19 % -23.15 % 6.52 % -16.18 % 69.35 %
Revenue In Millions $4.53 $3.68 $4.79 $4.49 $5.36
Gross Profit Margin 78.08 % 84.5 % 85.98 % 85.44 % 87.05 %
Gross Profit Margin Total Ranking # 971 # 1250 # 1306 # 1358 # 1560
Gross Profit In Millions $3.54 $3.11 $4.12 $3.84 $4.67
Y / Y Gross Profit Change -24.17 % 28.16 % 29.12 % 37.21 % 87.46 %
Seq. Gross Profit Change 13.84 % -24.47 % 7.19 % -17.72 % 92.41 %


Commenting fourth Quarter 2023 Gross Profit Margin
Liquidia has managed to improve its Revenue sequentially to $5 millions by 23.19 % faster than Gross Profit increase of 13.84 % to $4 millions, this led to contraction in Gross Profit Margin to 78.08 %, below company average.

Observing fourth quarter 2023 results within Major Pharmaceutical Preparations industry 97 other companies have achieved higher Gross Profit Margin. While Gross Profit Margin total ranking has impoved so far to 971, from total ranking in previous quarter at 1250.
Learn about Gross Margin
LQDA's Gross Profit Margin fourth quarter 2023 Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 98
Healthcare Sector # 168
Overall # 971

Gross Profit Margin Statistics
High Average Low
90 % 80.2 % 67.86 %
(Jun 30 2019)   (Dec 31 2020)




Other Gross Profit Margin Profitability Ratios
LQDA's Cumulative Gross Profit Margin
Major Pharmaceutical Preparations Industry Gross Profit Margin Trends and Statistics
Healthcare Sector Gross Profit Margin Statistics
Gross Profit Margin Profitability Trends for overall market
LQDA's Gross Profit Margin Profitability versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Gross Profit Margin
Lowest Ranking Gross Profit Margin
Gross Profit Margin Profit Margin for LQDA's Competitors
Gross Profit Margin Profit Margin for Liquidia's Suppliers
Gross Profit Margin Profit Margin for LQDA's Customers

You may also want to know
LQDA's Annual Growth Rates LQDA's Profitability Ratios LQDA's Asset Turnover Ratio LQDA's Dividend Growth
LQDA's Roe LQDA's Valuation Ratios LQDA's Financial Strength Ratios LQDA's Gross Profit Growth
LQDA's Roa LQDA's Inventory Turnover Ratio LQDA's Growth Rates LQDA's Dividend Comparisons


Companies with similar Gross Profit Margin in the quarter ending Dec 31 2023, within Major Pharmaceutical Preparations Industry Gross Profit MarginDec 31 2023 MRQ Gross ProfitDec 31 2023 MRQ Revenue
Blueprint Medicines Corporation  186.81 %$ 145.291 $ 77.776 
Royalty Pharma Plc  112.84 %$ 672.581 $ 596.068 
Abcellera Biologics Inc   100.00 %$ 9.178 $ 9.178 
Ac Immune Sa  100.00 %$ 14.801 $ 14.801 
Affimed N v   100.00 %$ 9.268 $ 9.268 
Alpine Immune Sciences Inc   100.00 %$ 30.853 $ 30.853 
Altimmune Inc   100.00 %$ 0.037 $ 0.037 
Anaptysbio Inc   100.00 %$ 9.005 $ 9.005 
Aprea Therapeutics Inc   100.00 %$ 0.583 $ 0.583 
Arrowhead Pharmaceuticals Inc   100.00 %$ 3.551 $ 3.551 
Azitra Inc   100.00 %$ 0.203 $ 0.203 
Bicycle Therapeutics Plc  100.00 %$ 5.331 $ 5.331 
Biofrontera Inc   100.00 %$ 52.086 $ 52.086 
Capricor Therapeutics inc   100.00 %$ 12.088 $ 12.088 
Cymabay Therapeutics Inc   100.00 %$ 0.057 $ 0.057 
Checkpoint Therapeutics Inc   100.00 %$ 0.006 $ 0.006 
Chimerix Inc   100.00 %$ 0.004 $ 0.004 
Cnbx Pharmaceuticals Inc   100.00 %$ 0.089 $ 0.089 
Centessa Pharmaceuticals Plc  100.00 %$ 6.853 $ 6.853 
Ensysce Biosciences Inc   100.00 %$ 0.671 $ 0.671 
Esperion Therapeutics inc   100.00 %$ 32.250 $ 32.250 
Foghorn Therapeutics Inc   100.00 %$ 5.769 $ 5.769 
Generation Bio Co   100.00 %$ 2.878 $ 2.878 
Glycomimetics Inc   100.00 %$ 0.010 $ 0.010 
G1 Therapeutics Inc   100.00 %$ 14.873 $ 14.873 
Hookipa Pharma inc   100.00 %$ 7.407 $ 7.407 
Werewolf Therapeutics Inc   100.00 %$ 1.501 $ 1.501 
Ironwood Pharmaceuticals inc   100.00 %$ 117.553 $ 117.553 
Intra cellular Therapies Inc   100.00 %$ 132.099 $ 132.099 
Jazz Pharmaceuticals Plc  100.00 %$ 1,011.935 $ 1,011.935 




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com